Trials / Active Not Recruiting
Active Not RecruitingNCT02740634
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.
Conditions
- Atypical Alzheimer's Disease
- Logopenic Progressive Aphasia (LPA)
- Posterior Cortical Atrophy (PCA)
- Alzheimer Disease
- Alzheimer Disease, Early Onset
- Amnestic Disorder
- Amnestic Symptoms
- Amnestic Mild Cognitive Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | F-18 AV 1451 | Tau binding agent |
| DRUG | C-11 PiB | Amyloid binding agent |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2016-04-15
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02740634. Inclusion in this directory is not an endorsement.